Surmodics - 20 Year Stock Price History | SRDX

Historical daily share price chart and data for Surmodics since 1998 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Surmodics as of October 22, 2018 is 63.91.
Surmodics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 50.1651 28.3500 80.3500 27.0000 63.9100 128.25%
2017 26.6009 25.9000 33.2000 22.5000 28.0000 10.24%
2016 23.6679 18.9900 30.4200 17.6200 25.4000 25.31%
2015 23.3890 22.1100 27.2600 20.1800 20.2700 -8.28%
2014 21.7201 24.2600 25.7900 18.1200 22.1000 -9.39%
2013 23.7374 23.2100 27.5500 19.7400 24.3900 9.08%
2012 16.9313 14.5200 22.3600 13.6900 22.3600 52.52%
2011 11.9297 11.8300 15.4000 8.8600 14.6600 23.50%
2010 15.7546 23.0000 23.0000 8.3300 11.8700 -47.62%
2009 22.2163 25.9900 30.6900 16.0100 22.6600 -10.33%
2008 38.5238 54.2800 54.2800 19.7000 25.2700 -53.44%
2007 43.4585 32.0500 56.7400 31.1100 54.2700 74.39%
2006 35.4589 37.3700 40.2200 31.1000 31.1200 -15.87%
2005 37.1368 31.5500 46.1300 28.0800 36.9900 13.78%
2004 23.8372 24.0800 32.9000 18.6000 32.5100 36.94%
2003 30.2065 29.4900 41.0500 20.1000 23.7400 -17.22%
2002 33.1802 35.8000 46.5000 19.9500 28.6800 -21.34%
2001 41.7589 31.5000 59.3700 23.2500 36.4600 -0.95%
2000 19.2425 15.2500 36.8100 10.0000 36.8100 145.40%
1999 7.7664 6.8750 16.0000 4.9375 15.0000 93.55%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.853B $0.073B
SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring innovation together for better patient outcomes. Recent collaborative efforts include the implementation of SurModics' Bravo drug delivery polymer matrix as a key component of the first-to-market drug-eluting coronary stent. SurModics is also active in the ophthalmology market with a sustained drug delivery system that is currently in human trials for treatment of retinal disease. A significant portion of SurModics' revenue is generated by royalties earned from the sale of our customers' commercial products.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.435B 19.38
Abbott Laboratories (ABT) United States $120.206B 24.38
Stryker (SYK) United States $62.741B 24.24
Boston Scientific (BSX) United States $50.643B 26.34
Baxter (BAX) United States $36.875B 25.10
Zimmer Biomet Holdings (ZBH) United States $25.257B 16.23
ResMed (RMD) United States $14.644B 29.07
Smith & Nephew SNATS (SNN) United Kingdom $14.612B 0.00
Perrigo (PRGO) Ireland $9.748B 13.83
Canopy Growth (CGC) Canada $9.572B 0.00
Bio-Rad Laboratories (BIO) United States $8.308B 53.35
Hill-Rom Holdings (HRC) United States $5.726B 19.42
Haemonetics (HAE) United States $5.555B 50.69
ICU Medical (ICUI) United States $5.444B 36.89
Insulet (PODD) United States $5.198B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.212B 0.00
Hutchison China MediTech (HCM) China $3.983B 0.00
Agios Pharmaceuticals (AGIO) United States $3.643B 0.00
Neogen (NEOG) United States $3.276B 49.61
NuVasive (NUVA) United States $3.270B 31.02
National Vision Holdings (EYE) United States $3.195B 70.55
Quidel (QDEL) United States $2.516B 51.55
NxStage Medical (NXTM) United States $1.836B 0.00
Phibro Animal Health (PAHC) United States $1.796B 25.58
Cardiovascular Systems (CSII) United States $1.258B 724.80
AtriCure (ATRC) United States $1.059B 0.00
VAREX IMAGING (VREX) United States $0.987B 16.12
Owens & Minor (OMI) United States $0.914B 9.77
OraSure Technologies (OSUR) United States $0.909B 59.44
Cerus (CERS) United States $0.879B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.875B 25.83
PetIQ (PETQ) United States $0.860B 28.12
MacroGenics (MGNX) United States $0.766B 0.00
Omeros (OMER) United States $0.749B 0.00
Meridian Bioscience (VIVO) United States $0.661B 22.59
Insys Therapeutics (INSY) United States $0.607B 0.00
LeMaitre Vascular (LMAT) United States $0.542B 26.98
Lantheus Holdings (LNTH) United States $0.510B 15.85
NanoString Technologies (NSTG) United States $0.452B 0.00
TG Therapeutics (TGTX) United States $0.423B 0.00
Quanterix (QTRX) United States $0.405B 0.00
Evolus (EOLS) United States $0.359B 0.00
Cytosorbents (CTSO) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.322B 20.76
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.295B 0.00
Surface Oncology (SURF) United States $0.230B 0.00
Rockwell Medical (RMTI) United States $0.221B 0.00
BioLife Solutions (BLFS) United States $0.209B 0.00
Chimerix (CMRX) United States $0.170B 0.00
Bovie Medical (BVX) United States $0.168B 0.00
Fonar (FONR) United States $0.146B 7.21
Chembio Diagnostics (CEMI) United States $0.140B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.136B 0.00
United-Guardian (UG) United States $0.079B 17.33
Imprimis Pharmaceuticals (IMMY) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.073B 0.00
Female Health (VERU) United States $0.073B 0.00
InfuSystems Holdings (INFU) United States $0.062B 0.00
Trinity Biotech (TRIB) Ireland $0.061B 18.19
Neurotrope (NTRP) United States $0.055B 0.00
CAS Medical Systems (CASM) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Akers Biosciences Inc (AKER) United States $0.035B 0.00
Valeritas Holdings (VLRX) United States $0.030B 0.00
Capricor Therapeutics (CAPR) United States $0.026B 0.00
Myomo (MYO) United States $0.022B 0.00
Senestech (SNES) United States $0.022B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00